Arteriosclerosis - Pipeline Review, H2 2013

1
Arteriosclerosis - Pipeline Review, H2 2013
Published Date December 2013

Price Single User US 2000
Corporate User US 6000
2
New Market Research Report on Arteriosclerosis -
Pipeline Review, H2 2013 added to
ReportsnReports.com
This report, ''Arteriosclerosis - Pipeline
Review, H2 2013'', provides an overview of the
indications therapeutic pipeline. This report
provides information on the therapeutic
development for Arteriosclerosis, complete with
latest updates, and special features on
late-stage and discontinued projects. It also
reviews key players involved in the therapeutic
development for Arteriosclerosis.
Arteriosclerosis - Pipeline Review, Half Year is
built using data and information sourced from
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Researchers team. Scope- A
snapshot of the global therapeutic scenario for
Arteriosclerosis.- A review of the
Arteriosclerosis products under development by
companies and universities/research institutes
based on information derived from company and
industry-specific sources.- Coverage of products
based on various stages of development ranging
from discovery till registration stages.- A
feature on pipeline projects on the basis of
monotherapy and combined therapeutics.- Coverage
of the Arteriosclerosis pipeline on the basis of
route of administration and molecule type.- Key
discontinued pipeline projects.- Latest news and
deals relating to the products. Inquire for a
discount _at_ http//www.reportsnreports.com/contacts
/discount.aspx?name267023 .
3
New Market Research Report on Arteriosclerosis -
Pipeline Review, H2 2013 added to
ReportsnReports.com
Reasons to buy- Identify and understand
important and diverse types of therapeutics under
development for Arteriosclerosis. - Identify
emerging players with potentially strong product
portfolio and design effective counter-strategies
to gain competitive advantage. - Plan mergers
and acquisitions effectively by identifying
players of the most promising pipeline. - Devise
corrective measures for pipeline projects by
understanding Arteriosclerosis pipeline depth and
focus of Indication therapeutics. - Develop and
design in-licensing and out-licensing strategies
by identifying prospective partners with the most
attractive projects to enhance and expand
business potential and scope. - Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline. Inquire for a discount _at_
http//www.reportsnreports.com/contacts/discount.a
spx?name267023 .
4
New Market Research Report on Arteriosclerosis -
Pipeline Review, H2 2013 added to
ReportsnReports.com
Table of Contents Table of Contents 2 List of
Tables 5List of Figures 6Introduction 7Report
Coverage 7Arteriosclerosis Overview
8Therapeutics Development 9Pipeline Products
for Arteriosclerosis - Overview 9Pipeline
Products for Arteriosclerosis - Comparative
Analysis 10Arteriosclerosis - Therapeutics under
Development by Companies 11Arteriosclerosis -
Therapeutics under Investigation by
Universities/Institutes 13Arteriosclerosis -
Pipeline Products Glance 14Late Stage Products
14Clinical Stage Products 15Early Stage
Products 16Arteriosclerosis - Products under
Development by Companies 17 Inquire for a
discount _at_ http//www.reportsnreports.com/contacts
/discount.aspx?name267023 .
5
New Market Research Report on Arteriosclerosis -
Pipeline Review, H2 2013 added to
ReportsnReports.com
Arteriosclerosis - Products under Investigation
by Universities/Institutes 18Arteriosclerosis -
Companies Involved in Therapeutics Development
19Johnson Johnson 19Kowa Company, Ltd.
20Nippon Shinyaku Co., Ltd. 21KunWha
Pharmaceutical Co., Ltd. 22AnGes MG, Inc. 23LTT
Bio-Pharma Co., Ltd. 24CytoTools AG 25Angelini
Group 26ECI, Inc. 27Arteriosclerosis -
Therapeutics Assessment 28Assessment by
Monotherapy Products 28Assessment by Target 29
Inquire for a discount _at_ http//www.reportsnrep
orts.com/contacts/discount.aspx?name267023 .
Table of Contents
6
New Market Research Report on Arteriosclerosis -
Pipeline Review, H2 2013 added to
ReportsnReports.com
Assessment by Mechanism of Action 32Assessment
by Route of Administration 35Assessment by
Molecule Type 37Assessment by Therapeutic Class
39Drug Profiles 42beperminogene perplasmid -
Drug Profile 42Product Description 42Mechanism
of Action 42RD Progress 42ecraprost - Drug
Profile 45Product Description 45Mechanism of
Action 45RD Progress 45K-134 - Drug Profile
47Product Description 47Mechanism of Action
47RD Progress 47selexipag - Drug Profile
48 Inquire for a discount _at_ http//www.reportsnr
eports.com/contacts/discount.aspx?name267023 .
Table of Contents
7
About ReportsnReports
ReportsnReports.com is your single source for all
market research needs. Our database includes
250,000 syndicated market research reports from
100 leading global publishers covering in-depth
analysis of over 5000 micro markets. With
comprehensive information about the publishers
and their report methodology, data sources, etc.
we help you in your purchase decision by mapping
your information needs with the most relevant
available reports in our library. Connect with
us sales_at_reportsandreports.com 1 888 391 5441
Contact sales_at_reportsandreports.com for further
information.
Contact sales_at_reportsandreports.com for further
information.